Insilico Medicine
Industry
- Biotechnology
- Drug Discovery Technologies
- Pharmaceuticals
- Digital Health
- Artificial Intelligence
Latest on Insilico Medicine
“This is the time to stand up together and say “no” to what the [US] Administration is doing,” said a pharmaceutical industry executive during a January 2025 conference call. Since then, President Tru
Artificial intelligence (AI)-driven drug discovery company Insilico Medicine is fast-tracking its first-in-class small molecule targeting Traf2- and Nck-interacting kinase (TNIK) into a Phase III stud
The number of venture capital mega-rounds of $100m or more plummeted from 11 in January to just three in February, but appear to be on the rise again with five as of mid-March. Flagship Pioneering’s l
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Deal Brings AstraZeneca Greater C